Here's Why China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt Responsibly
China Resources Double-Crane Pharmaceutical Gets Drug Registration for Neurological Disease Tablets
Express News | Crane NXT Co - Aggregate Principal Amount of Revolving Commitments Is $700 Million
Express News | Crane NXT Co - Enters Second Amendment to Credit Agreement
Saudi Arabia Crane Market Report 2024 - The Rise of Electric and Hybrid Cranes and Increased Demand for Crane Rentals - A USD 1.68 Billion Market by 2029
Crane Company Announces Promotion of Alejandro (Alex) Alcala to Chief Operating Officer
